SB 5642
In CommitteeSenate
Medicaid clients/metrics
Improving performance on maternal health and preventative cancer screening metrics for medicaid clients.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill aims to improve maternal and cancer screening outcomes for Washington’s Medicaid clients by requiring the state to develop outreach materials, performance incentives, and reporting systems focused on prenatal care, postpartum care, breast cancer screening, and cervical cancer screening. It also mandates specific actions to support early pregnancy identification and accountability for managed care and fee-for-service providers.
- Require the Health Care Authority (HCA), in collaboration with the Department of Health and other partners, to develop education and outreach materials by December 31, 2025 to improve performance on maternal health and cancer screening metrics for Medicaid clients.
- Develop an implementation plan by December 31, 2025 to incentivize Medicaid managed care organizations and fee-for-service providers to improve performance on breast cancer screening, cervical cancer screening, timeliness of prenatal care, and postpartum care.
- Require the HCA to submit an annual report to the governor and legislature starting November 30, 2028, detailing progress, savings, and data on client eligibility and service delivery for the four key metrics.
- Require the HCA to develop billing instructions for fee-for-service providers and amend managed care contracts to encourage use of CPT code 0500F (a code for early pregnancy identification) as part of performance incentives.
- Define the role of the external quality improvement organization (as defined by federal regulation) in measuring performance for accountability purposes.
Who is affected
- Medicaid clients (especially pregnant and postpartum women) — Medicaid clients who are pregnant or of reproductive age, who may benefit from improved access to timely prenatal care, postpartum care, and cancer screenings (breast and cervical).
- Health care providers in fee-for-service Medicaid — Providers who serve Medicaid patients in fee-for-service settings (e.g., obstetricians, gynecologists, primary care providers, cancer screening clinics), who will need to follow new billing guidance and may be incentivized to improve performance.
- Medicaid managed care organizations — Managed care organizations (MCOs) that contract with the state to provide Medicaid services, who must develop and implement performance improvement plans and report annually on outcomes.
- Washington State Health Care Authority and Department of Health — State agencies and oversight bodies responsible for monitoring and reporting on health care quality and cost-effectiveness for Medicaid.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (4)
The bill directly targets gaps in maternal and cancer screening care for Medicaid clients—particularly low-income pregnant women and women of reproductive age—who face higher rates of maternal mortality, delayed cancer diagnosis, and barriers to timely care. By mandating outreach, incentives, and standardized performance tracking, it aims to reduce preventable deaths and improve long-term health outcomes for a vulnerable population.
HealthcarePeopleRef: Sec. 1(1)(a)-(d); Sec. 2; Sec. 3(1)Requiring use of CPT code 0500F (early pregnancy identification) and tracking timeliness of prenatal/postpartum care creates a measurable pathway to catch high-risk pregnancies earlier—potentially reducing preterm births, maternal complications, and long-term neonatal costs. Early intervention is especially critical for Medicaid clients, who often present later in pregnancy due to access barriers.
HealthcarePeopleRef: Sec. 4(1) & Sec. 3(2)(k)-(l)Annual public reporting on performance metrics—including savings, eligibility, and service utilization—enhances transparency and accountability for state-spent healthcare dollars. This data-driven oversight can help identify effective interventions, reduce waste, and inform future policy, ultimately improving system efficiency for all Medicaid enrollees.
HealthcarePeopleRef: Sec. 3(2)(a)-(m)By tying performance incentives to cost containment and outcomes, the bill may encourage health systems to adopt value-based care models—potentially creating demand for new roles in population health management, data analytics, and care coordination, especially in community health centers and MCOs.
Business & EmploymentLean peopleRef: Sec. 1(1)(f); Sec. 3(2)
Potential Concerns (3)
The bill requires annual reporting to the legislature and governor starting in 2028, including detailed data on client eligibility, service delivery, and performance metrics—adding administrative burden to state agencies (HCA and DOH) and potentially diverting resources from direct service delivery. While not a direct cost to local governments, this increases state-level administrative demands that may strain already-constrained public health infrastructure.
Local GovernmentRef: Sec. 3(2)(e)-(m)The performance incentive structure relies on Medicaid managed care organizations (MCOs) and fee-for-service providers to improve metrics, but the bill does not specify funding for those incentives—creating risk that providers will absorb costs without guaranteed reimbursement, potentially leading to reduced participation or service cuts in under-resourced areas. This could disproportionately affect safety-net providers serving high-need populations.
HealthcarePeopleRef: Sec. 3(1) & Sec. 4(2)The requirement to develop outreach materials and billing instructions by December 31, 2025—without specifying dedicated funding—may strain state agency resources, especially given overlapping mandates (e.g., HCA’s existing workload on Medicaid expansion, DOH’s public health priorities). Delays or under-resourcing could undermine the bill’s goals before implementation even begins.
HealthcareLean peopleRef: Sec. 2 & Sec. 4(1)
Who Is Most Affected
Low-income pregnant and postpartum women—especially those in rural or underserved urban areas—stand to benefit significantly from improved access to timely prenatal and postpartum care, and earlier detection of breast/cervical cancer. However, if incentives fail to reach safety-net providers, they may see no improvement or even reduced access if providers drop Medicaid due to administrative strain.
Fee-for-service providers (e.g., OB-GYNs, primary care clinicians) may benefit from new billing guidance and potential performance incentives, but face added administrative work without guaranteed reimbursement. Small practices in underserved areas may struggle to meet reporting requirements without technical support.
MCOs will need to revise contracts and implement performance improvement plans—potentially incurring upfront costs. Those with strong maternal-child health programs may gain reputational or financial advantage, while others may face penalties or reduced capitation rates if they underperform.
HCA and DOH gain new authority and reporting responsibilities, increasing their oversight role but also their workload. These agencies may benefit from enhanced data infrastructure and interagency collaboration, but could face political pressure if outcomes lag or costs rise.